State of Wyoming Takes Position in Pediatrix Medical Group, Inc. $MD

State of Wyoming bought a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 23,465 shares of the company’s stock, valued at approximately $594,000.

Several other large investors also recently made changes to their positions in MD. Global Retirement Partners LLC lifted its stake in Pediatrix Medical Group by 68,250.0% during the fourth quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock valued at $29,000 after purchasing an additional 1,365 shares during the last quarter. Transamerica Financial Advisors LLC acquired a new position in Pediatrix Medical Group in the fourth quarter worth approximately $30,000. Eurizon Capital SGR S.p.A. acquired a new position in Pediatrix Medical Group in the fourth quarter worth approximately $33,000. TD Private Client Wealth LLC bought a new position in shares of Pediatrix Medical Group in the fourth quarter valued at $39,000. Finally, Los Angeles Capital Management LLC bought a new position in shares of Pediatrix Medical Group in the fourth quarter valued at $43,000. Institutional investors own 97.71% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on MD shares. UBS Group increased their price objective on Pediatrix Medical Group from $25.00 to $28.00 and gave the company a “neutral” rating in a research report on Thursday, August 6th. Truist Financial lifted their target price on Pediatrix Medical Group from $23.00 to $28.00 and gave the stock a “hold” rating in a report on Tuesday, July 14th. Jefferies Financial Group reaffirmed a “buy” rating and set a $27.00 target price on shares of Pediatrix Medical Group in a research report on Monday, April 20th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $25.00 target price on shares of Pediatrix Medical Group in a report on Wednesday, August 5th. Finally, Weiss Ratings upgraded Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday, August 4th. Two investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $24.83.

Pediatrix Medical Group Trading Down 0.1%

NYSE MD opened at $26.58 on Monday. Pediatrix Medical Group, Inc. has a twelve month low of $15.59 and a twelve month high of $27.94. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.32 and a current ratio of 1.32. The stock has a market cap of $2.16 billion, a price-to-earnings ratio of 12.72 and a beta of 0.66. The firm’s 50 day moving average price is $25.49 and its two-hundred day moving average price is $22.80.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.59 by $0.04. The company had revenue of $487.78 million during the quarter, compared to analyst estimates of $478.49 million. Pediatrix Medical Group had a return on equity of 20.05% and a net margin of 8.96%.The company’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.53 earnings per share. Equities analysts anticipate that Pediatrix Medical Group, Inc. will post 2.15 EPS for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.